Efficacy and Safety of Atomoxetine in Adolescents with Attention-Deficit/Hyperactivity Disorder and Major Depression
Authors:
- 1 August 2007
- journal article
- research article
- Published by SAGE Publications in Journal of Child and Adolescent Psychopharmacology
- Vol. 17 (4) , 407-419
Abstract
This double-blind study examined efficacy and safety of atomoxetine (ATX; ≤1.8mg/kg per day) in adolescents aged 12–18 with Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) diagnoses of both attention-deficit/hyperactivity disorder (ADHD) and co-morbid major depressive disorder (MDD). Diagnoses were confirmed by the Kiddie Schedule for Affective Disorders and Schizophrenia for School Age Children–Present and Lifetime Version and persistently elevated scores on the Attention-Deficit/Hyperactivity Disorder Rating Scale-IV, Parent version, Investigator-administered and -scored (ADHDRS-IV-Parent:Inv, ≥1.5 standard deviations above age and gender norms) and Children's Depression Rating Scale–Revised (CDRS-R, ≥ 40). Patients were treated for approximately 9 weeks with ATX (n = 72) or placebo (n = 70). Mean decrease in ADHDRS-IV-Parent:Inv total score was significantly greater in the ATX group (−13.3 ± 10.0) compared with the placebo group (−5.1 ± 9.9; p < 0.001). Mean CDRS-R score improvement was not significantly different between groups (ATX, −14.8 ± 13.3; placebo, −12.8 ± 10.4). Rates of treatment-emergent mania did not differ between groups (ATX, 0.0%; placebo, 1.5%). ATX treatment was associated with significantly more nausea and decreased appetite (p = 0.002; p = 0.003). No spontaneously reported adverse events involving suicidal ideation or suicidal behavior occurred in either group. ATX was an effective and safe treatment for ADHD in adolescents with ADHD and MDD. However, this trial showed no evidence for ATX of efficacy in treating MDD.Keywords
This publication has 26 references indexed in Scilit:
- Efficacy of Atomoxetine Versus Placebo in School-Age Girls With Attention-Deficit/Hyperactivity DisorderPediatrics, 2002
- Comparison of Attention-Deficit/Hyperactivity Disorder Symptom Subtypes in Ukrainian SchoolchildrenJournal of the American Academy of Child & Adolescent Psychiatry, 2000
- DSM-IV AD/HD: Confirmatory Factor Models, Prevalence, and Gender and Age Differences Based on Parent and Teacher Ratings of Australian Primary School ChildrenJournal of Child Psychology and Psychiatry, 1999
- Predictors of Persistence and Remission of ADHD into Adolescence: Results from a Four-Year Prospective Follow-up StudyJournal of the American Academy of Child & Adolescent Psychiatry, 1996
- Rate and Predictors of Prepubertal Bipolarity during Follow-up of 6- to 12-Year-Old Depressed ChildrenJournal of the American Academy of Child & Adolescent Psychiatry, 1994
- Psychiatric Risk Factors for Adolescent Suicide: A Case-Control StudyJournal of the American Academy of Child & Adolescent Psychiatry, 1993
- Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disordersAmerican Journal of Psychiatry, 1991
- Comorbidity of other psychiatric disturbances in depressed, psychiatrically hospitalized childrenAmerican Journal of Psychiatry, 1988
- Estimnates of the Prevalence of Childhood Maladjustment in a Community Survey in Puerto RicoArchives of General Psychiatry, 1988
- DSM-III Disorders in Preadolescent ChildrenArchives of General Psychiatry, 1987